Nonpartisan civic infrastructure
AllCiv·Legis1
·

H.R. 6545

BillFederalHouseIn Committee
To amend the Federal Food, Drug, and Cosmetic Act to expand certain authorities with respect to the recall of controlled substances to apply with respect to all drugs, and for other purposes.
About This Bill
Committee
Latest Action · February 2, 2022
Referred to the Subcommittee on Health.
Congress
117th (2021–2023)
Introduced
February 1, 2022
Cosponsors (0)
None
View PDF ↗

Summary

Highlight any text to annotate
Protecting Americans from Unsafe Drugs Act of 2022 This bill expands the authority of the Secretary of the Department of Health and Human Services (HHS) to order the recall of controlled substances to cover all drugs. Furthermore, the authority to issue such an order may be delegated to the Director of the Center for Drug Evaluation and Research or the Director of the Center for Biologics Evaluation and Research (or an official senior to either director), whereas currently this authority may only be delegated to the Director of the Center for Drug Evaluation and Research or an official senior to such director. (Both centers are located in the Food and Drug Administration within HHS.)

Take Action

Your position
Add a comment
to comment on this bill.
Annotate the text
Highlight any passage on the Summary or Full Text tab to attach a note. Annotations appear on the Annotations tab.